Our study demonstrates that Plin5 protects against NASH progression by increasing 11-Dodecenoic acid level and further inhibiting ferroptosis, suggesting that Plin5 has therapeutic potential as a target for the management of NASH. Here, PLIN5 is linked to metabolic dysfunction-associated steatohepatitis.